In 1989 a patient with myalgic encephalomyelitis (ME) came to see Dr Raymond Perrin in his capacity as an osteopath. The man ...

The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

Tezspire is currently approved for the treatment of severe asthma in the US, EU, Japan, and nearly 60 countries across the globe. It is approved as a single-use pre-filled syringe and auto-injector ...

Coughs, sneezes, runny noses, sore throats, sinus infections ... including people age 65 and older, adults with chronic heart ...

Pneumonia in the elderly can quickly become serious and deadly. On World Pneumonia Day, know the symptoms of this infection ...

Company reports Q3 2024 XHANCE net revenue of $20.4 million, an increase of 3% compared to Q3 2023 Company reports positive inflection in new prescriptions of XHANCE starting in September Company ...

Company reports Q3 2024 XHANCE net revenue of $20.4 million, an increase of 3% compared to Q3 2023 Company reports positive inflection in new prescriptions of XHANCE starting in September Company decr ...